<SEC-DOCUMENT>0001567619-21-013989.txt : 20210726
<SEC-HEADER>0001567619-21-013989.hdr.sgml : 20210726
<ACCEPTANCE-DATETIME>20210726193228
ACCESSION NUMBER:		0001567619-21-013989
CONFORMED SUBMISSION TYPE:	3
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20210716
FILED AS OF DATE:		20210726
DATE AS OF CHANGE:		20210726

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Genting Berhad
		CENTRAL INDEX KEY:			0001788489

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38914
		FILM NUMBER:		211115524

	BUSINESS ADDRESS:	
		STREET 1:		24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			50250
		BUSINESS PHONE:		60 3 2178 2288

	MAIL ADDRESS:	
		STREET 1:		24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA LUMPUR
		STATE:			N8
		ZIP:			50250

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Dragasac Ltd
		CENTRAL INDEX KEY:			0001872884
		STATE OF INCORPORATION:			Y8
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		3
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38914
		FILM NUMBER:		211115525

	BUSINESS ADDRESS:	
		STREET 1:		C/O 24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA  LUMPUR
		STATE:			N8
		ZIP:			50250
		BUSINESS PHONE:		603 2333 6888

	MAIL ADDRESS:	
		STREET 1:		C/O 24TH FLOOR, WISMA GENTING
		STREET 2:		JALAN SULTAN ISMAIL
		CITY:			KUALA  LUMPUR
		STATE:			N8
		ZIP:			50250

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Celularity Inc
		CENTRAL INDEX KEY:			0001752828
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				831702591
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019
		BUSINESS PHONE:		2126163700

	MAIL ADDRESS:	
		STREET 1:		1325 AVENUE OF THE AMERICAS
		STREET 2:		25TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GX Acquisition Corp.
		DATE OF NAME CHANGE:	20180912
</SEC-HEADER>
<DOCUMENT>
<TYPE>3
<SEQUENCE>1
<FILENAME>doc1.xml
<DESCRIPTION>FORM 3
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0206</schemaVersion>

    <documentType>3</documentType>

    <periodOfReport>2021-07-16</periodOfReport>

    <noSecuritiesOwned>0</noSecuritiesOwned>

    <issuer>
        <issuerCik>0001752828</issuerCik>
        <issuerName>Celularity Inc</issuerName>
        <issuerTradingSymbol>CELU</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001872884</rptOwnerCik>
            <rptOwnerName>Dragasac Ltd</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O 24TH FLOOR, WISMA GENTING</rptOwnerStreet1>
            <rptOwnerStreet2>JALAN SULTAN ISMAIL</rptOwnerStreet2>
            <rptOwnerCity>KUALA  LUMPUR</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>50250</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001788489</rptOwnerCik>
            <rptOwnerName>Genting Berhad</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>24TH FLOOR, WISMA GENTING</rptOwnerStreet1>
            <rptOwnerStreet2>JALAN SULTAN ISMAIL</rptOwnerStreet2>
            <rptOwnerCity>KUALA LUMPUR</rptOwnerCity>
            <rptOwnerState>N8</rptOwnerState>
            <rptOwnerZipCode>50250</rptOwnerZipCode>
            <rptOwnerStateDescription>MALAYSIA</rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
            <officerTitle></officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Class A Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>30062778</value>
                    <footnoteId id="F1"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable>
        <derivativeHolding>
            <securityTitle>
                <value>Warrants (Right to Buy)</value>
            </securityTitle>
            <conversionOrExercisePrice>
                <value>6.77</value>
            </conversionOrExercisePrice>
            <exerciseDate>
                <value>2021-07-16</value>
            </exerciseDate>
            <expirationDate>
                <footnoteId id="F4"/>
            </expirationDate>
            <underlyingSecurity>
                <underlyingSecurityTitle>
                    <value>Class A Common Stock</value>
                </underlyingSecurityTitle>
                <underlyingSecurityShares>
                    <value>6529818</value>
                    <footnoteId id="F3"/>
                </underlyingSecurityShares>
            </underlyingSecurity>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                    <footnoteId id="F2"/>
                </directOrIndirectOwnership>
            </ownershipNature>
        </derivativeHolding>
    </derivativeTable>

    <footnotes>
        <footnote id="F1">These shares of Class A Common Stock were acquired in connection with the merger of GX Acquisition Corp. (&quot;GX&quot;), two of its wholly owned subsidiaries and Celularity Inc. (&quot;Celularity&quot;) (the &quot;Merger&quot;), which closed on July 16, 2021 (&quot;Closing&quot;).  At Closing, Dragasac Limited (&quot;Dragasac&quot;) acquired (i) 26,562,778 shares of Class A Common Stock in exchange for 34,560,219 shares of Series B Preferred Stock of Celularity and (ii) 3,500,000 shares of Class A Common Stock acquired directly from the Issuer in a private placement pursuant to a subscription agreement with the Issuer. On the Closing date, the closing price of the Issuer's Class A Common Stock was $10.20.</footnote>
        <footnote id="F2">These securities are directly held by Dragasac, which is an indirect wholly-owned subsidiary of Genting Berhad, a public company listed on the Malaysian stock exchange. Lim Kok Thay, who serves as a director on the Issuer's board of directors, is an indirect beneficial owner of the largest shareholder of Genting Berhad, where he serves as Chief Executive and Chairman of the Board. Mr. Lim separately files section 16 reports.  Genting Berhad disclaims beneficial ownership over the reported securities except to the extent of its pecuniary interest therein.</footnote>
        <footnote id="F3">These warrants to acquire Class A Common Stock were acquired in connection with the Merger in exchange for warrants to acquire 8,495,796 shares of Series B Preferred Stock of Celularity that had an exercise price per share equal to the lesser of (a) $5.20 per share or (b) 80% of either (i) the value attributed to one share of Series B Preferred Stock of Celularity upon consummation of a change in control or the closing of a strategic transaction pursuant to which Celularity's stockholders exchange their existing shares of capital stock in Celularity for shares in a company whose shares are listed on a national stock exchange or (ii) the price at which one share of Celularity common stock is sold to the public market in an initial public offering.</footnote>
        <footnote id="F4">These warrants expire upon the earlier to occur of (i) March 16, 2025, or (ii), the consummation of a change in control of the Issuer.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>Dragasac Limited By: /s/ Tan Kong Han, Director</signatureName>
        <signatureDate>2021-07-26</signatureDate>
    </ownerSignature>

    <ownerSignature>
        <signatureName>Genting Berhad By: /s/ Loh Bee Hong, Elaine, Company Secretary</signatureName>
        <signatureDate>2021-07-26</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
